Incorporated in 1998, Indegene Ltd provides
solutions consisting of analytics, technology and commercial, medical, regulatory and
safety services to life science and health
care organizations
Financial Results:
Indegene Ltd reported Revenues for Q2FY25 of ₹687.00 Crores up from ₹636.00 Crore year on year, a rise of 8.02%.
Total Expenses for Q2FY25 of ₹584.00 Crores up from ₹547.00 Crores year on year, a rise of 6.76%.
Consolidated Net Profit of ₹92.00 Crores up 22.67% from ₹75.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹3.83, up 13.31% from ₹3.38 in the same quarter of the previous year.